Three doses of mRNA Covid-19 vaccines, either Pfizer-BioNTech or Moderna, are effective in protecting against emergency department visits (ED) and hospitalisations associated with Omicron and Delta variations of the virus, claims a new study.
The study, from the US Centers for Disease Control and Prevention (CDC), found that boosters of mRNA Covid vaccines are 82 per cent effective in protecting against Omicron variant-associated ED visits.
It also found that booster shots are 90 per cent effective in protecting against Omicron variant-related hospitalisations.
"Our findings provide important evidence that booster shots are highly effective and those who are unvaccinated are at significantly greater risk of experiencing more severe Covid-19 outcomes and should get vaccinated and boostered as soon as possible," researcher Shaun Grannis from Indiana University, said.
The value of the third dose of an mRNA vaccine is significant as two doses were only 38 per cent effective in protecting against Omicron-related ED visits and only 57 per cent effective in protecting against Covid Omicron variant-related hospitalisations.
Boosters were even more effective against the Delta variant of Covid, protecting against 94 per cent of both Covid Delta variant associated ED visits and hospitalisations.
The CDC collaborated with six US healthcare systems to create the VISION network to assess Covid vaccine effectiveness.
--IANS
vc/sks/ksk/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)